<DOC>
	<DOCNO>NCT01290315</DOCNO>
	<brief_summary>The purpose study compare safety oxidative stress potential two dos investigational IV iron , ferric carboxymaltose ( FCM ) , compare equal single dose IV iron sucrose IV iron dextran treatment Iron Deficiency Anemia ( IDA ) female subject .</brief_summary>
	<brief_title>Intravenous Ferric Carboxymaltose ( FCM ) Versus IV Iron Sucrose IV Iron Dextran Treating Iron Deficiency Anemia Women</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Iron-Dextran Complex</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Female subject 1850 year age able give inform consent . If postpartum , least 10 day post delivery Day 0 . Screening Visit local laboratory Hgb &lt; = 10 g/dL &lt; = 12 g/dL symptom ( dizziness and/or fatigue ) . Screening Visit ferritin &lt; = 100 ng/mL &lt; = 300 TSAT &lt; = 30 % . Documented unsatisfactory response intolerance oral iron . Previous participation ferric carboxymaltose ( FCM ) clinical trial . Known hypersensitivity reaction component ferric carboxymaltose , Venofer , Dexferrum . History drug allergy history rheumatoid arthritis autoimmune disease . Current anemia attribute iron deficiency . During 10 day period prior screen treat antibiotic . During 30 day period prior screen study period treat erythropoiesis stimulating agent . Active malignancy within 5 year . Basal squamous cell skin cancer exclusionary . During 30 day period prior screen study period require surgical procedure necessitate general anesthesia . Current ( acute chronic ) infection viral upper respiratory tract infection . AST ALT screen great 1.5 time upper limit normal . Known positive hepatitis B evidence active hepatitis . Known positive HIV1/HIV2 antibody ( antiHIV ) . Patient active diagnosis asthma currently use anti asthmatic therapy . Received investigational drug within 30 day screen . Alcohol drug abuse within past 6 month . Hemochromatosis iron storage disorder . Systolic blood pressure &gt; = 180 &lt; 80 mmHg diastolic blood pressure &gt; = 100 &lt; 40 mmHg screen Day 0 . Chronic kidney disease . Chronic inflammatory condition include limited Lupus Rheumatoid Arthritis . Preterm delivery &lt; 32 week . Emergent Csection delivery . Significant cardiovascular disease , include limited myocardial infarction unstable angina within 6 month prior study inclusion current history NYHA Class III IV congestive heart failure . Any laboratory abnormality , medical condition psychiatric disorder opinion investigator put subject 's disease management risk may result subject unable comply study requirement . Night shift worker . Breastfeeding plan Day 0 . Pregnant sexuallyactive female subject childbearing potential n't use acceptable form contraception .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>